Monoclonal gammopathy‐associated thrombotic microangiopathy

Thrombotic microangiopathy (TMA) represents a heterogeneous group of clinical syndromes with end-organ damage resulting from endothelial injury secondary to a variety of etiologies.1 Manifestations of TMA can be divided into peripheral which include thrombocytopenia and microangiopathic hemolytic anemia (MAHA), and renal including vascular thrombosis, mesangiolysis, endothelial swelling, and subendothelial accumulation of cellular material.2...